Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 11 |
GO:0042995 | cell projection | 2 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4H4G5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 213 | 217 | PF00656 | 0.518 |
CLV_C14_Caspase3-7 | 256 | 260 | PF00656 | 0.570 |
CLV_C14_Caspase3-7 | 394 | 398 | PF00656 | 0.448 |
CLV_C14_Caspase3-7 | 55 | 59 | PF00656 | 0.795 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.413 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.511 |
CLV_NRD_NRD_1 | 415 | 417 | PF00675 | 0.607 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.474 |
CLV_PCSK_KEX2_1 | 380 | 382 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 415 | 417 | PF00082 | 0.619 |
CLV_PCSK_PC1ET2_1 | 380 | 382 | PF00082 | 0.457 |
CLV_PCSK_PC7_1 | 411 | 417 | PF00082 | 0.695 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.551 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.700 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.548 |
DEG_COP1_1 | 149 | 159 | PF00400 | 0.580 |
DOC_CYCLIN_RxL_1 | 197 | 206 | PF00134 | 0.411 |
DOC_CYCLIN_yClb1_LxF_4 | 19 | 24 | PF00134 | 0.526 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 116 | 123 | PF00134 | 0.416 |
DOC_MAPK_DCC_7 | 14 | 24 | PF00069 | 0.525 |
DOC_MAPK_gen_1 | 380 | 390 | PF00069 | 0.424 |
DOC_MAPK_MEF2A_6 | 383 | 392 | PF00069 | 0.415 |
DOC_MAPK_NFAT4_5 | 385 | 393 | PF00069 | 0.410 |
DOC_MAPK_RevD_3 | 102 | 117 | PF00069 | 0.432 |
DOC_PP1_RVXF_1 | 19 | 25 | PF00149 | 0.527 |
DOC_USP7_MATH_1 | 310 | 314 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.795 |
LIG_14-3-3_CanoR_1 | 133 | 140 | PF00244 | 0.300 |
LIG_14-3-3_CanoR_1 | 242 | 248 | PF00244 | 0.546 |
LIG_14-3-3_CanoR_1 | 95 | 100 | PF00244 | 0.446 |
LIG_14-3-3_CterR_2 | 415 | 418 | PF00244 | 0.728 |
LIG_Actin_WH2_2 | 172 | 189 | PF00022 | 0.539 |
LIG_Clathr_ClatBox_1 | 96 | 100 | PF01394 | 0.443 |
LIG_deltaCOP1_diTrp_1 | 352 | 359 | PF00928 | 0.492 |
LIG_FHA_1 | 366 | 372 | PF00498 | 0.399 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.300 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.398 |
LIG_FHA_2 | 196 | 202 | PF00498 | 0.363 |
LIG_FHA_2 | 324 | 330 | PF00498 | 0.585 |
LIG_FHA_2 | 392 | 398 | PF00498 | 0.492 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.558 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.522 |
LIG_LIR_Gen_1 | 180 | 189 | PF02991 | 0.392 |
LIG_LIR_Gen_1 | 216 | 226 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 384 | 393 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 180 | 186 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 318 | 324 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 352 | 356 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 384 | 390 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 397 | 402 | PF02991 | 0.447 |
LIG_LRP6_Inhibitor_1 | 139 | 145 | PF00058 | 0.430 |
LIG_LRP6_Inhibitor_1 | 204 | 210 | PF00058 | 0.405 |
LIG_LRP6_Inhibitor_1 | 226 | 232 | PF00058 | 0.425 |
LIG_MAD2 | 38 | 46 | PF02301 | 0.768 |
LIG_MYND_3 | 337 | 341 | PF01753 | 0.486 |
LIG_OCRL_FandH_1 | 5 | 17 | PF00620 | 0.509 |
LIG_PCNA_PIPBox_1 | 337 | 346 | PF02747 | 0.433 |
LIG_Pex14_2 | 2 | 6 | PF04695 | 0.484 |
LIG_PTB_Apo_2 | 386 | 393 | PF02174 | 0.553 |
LIG_SH2_CRK | 183 | 187 | PF00017 | 0.406 |
LIG_SH2_CRK | 387 | 391 | PF00017 | 0.434 |
LIG_SH2_GRB2like | 387 | 390 | PF00017 | 0.560 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 370 | 373 | PF00017 | 0.417 |
LIG_SH3_1 | 14 | 20 | PF00018 | 0.525 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.525 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.536 |
LIG_SH3_3 | 328 | 334 | PF00018 | 0.501 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.680 |
LIG_SUMO_SIM_par_1 | 315 | 320 | PF11976 | 0.326 |
LIG_TYR_ITIM | 181 | 186 | PF00017 | 0.381 |
LIG_UBA3_1 | 112 | 117 | PF00899 | 0.301 |
LIG_UBA3_1 | 23 | 32 | PF00899 | 0.723 |
LIG_WRC_WIRS_1 | 215 | 220 | PF05994 | 0.548 |
LIG_WW_3 | 18 | 22 | PF00397 | 0.529 |
MOD_CK1_1 | 194 | 200 | PF00069 | 0.539 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.462 |
MOD_CK1_1 | 260 | 266 | PF00069 | 0.329 |
MOD_CK2_1 | 195 | 201 | PF00069 | 0.399 |
MOD_CK2_1 | 260 | 266 | PF00069 | 0.489 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.354 |
MOD_CK2_1 | 301 | 307 | PF00069 | 0.472 |
MOD_CK2_1 | 323 | 329 | PF00069 | 0.551 |
MOD_CK2_1 | 56 | 62 | PF00069 | 0.692 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.465 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.432 |
MOD_GlcNHglycan | 122 | 126 | PF01048 | 0.564 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.531 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.594 |
MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.477 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.503 |
MOD_GSK3_1 | 253 | 260 | PF00069 | 0.346 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.576 |
MOD_GSK3_1 | 391 | 398 | PF00069 | 0.496 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.684 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.693 |
MOD_N-GLC_1 | 327 | 332 | PF02516 | 0.339 |
MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.644 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.441 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.458 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.372 |
MOD_NEK2_1 | 195 | 200 | PF00069 | 0.393 |
MOD_NEK2_1 | 317 | 322 | PF00069 | 0.437 |
MOD_NEK2_1 | 362 | 367 | PF00069 | 0.406 |
MOD_NEK2_2 | 310 | 315 | PF00069 | 0.498 |
MOD_PIKK_1 | 391 | 397 | PF00454 | 0.524 |
MOD_PK_1 | 253 | 259 | PF00069 | 0.472 |
MOD_PK_1 | 276 | 282 | PF00069 | 0.367 |
MOD_PKA_1 | 187 | 193 | PF00069 | 0.535 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.301 |
MOD_PKA_2 | 187 | 193 | PF00069 | 0.313 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.341 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.496 |
MOD_Plk_1 | 179 | 185 | PF00069 | 0.381 |
MOD_Plk_1 | 317 | 323 | PF00069 | 0.362 |
MOD_Plk_1 | 327 | 333 | PF00069 | 0.436 |
MOD_Plk_1 | 69 | 75 | PF00069 | 0.761 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.550 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.437 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.538 |
MOD_Plk_4 | 327 | 333 | PF00069 | 0.584 |
MOD_SUMO_rev_2 | 103 | 113 | PF00179 | 0.567 |
MOD_SUMO_rev_2 | 136 | 144 | PF00179 | 0.397 |
MOD_SUMO_rev_2 | 201 | 209 | PF00179 | 0.401 |
MOD_SUMO_rev_2 | 28 | 33 | PF00179 | 0.618 |
MOD_SUMO_rev_2 | 352 | 359 | PF00179 | 0.489 |
TRG_DiLeu_BaEn_1 | 160 | 165 | PF01217 | 0.395 |
TRG_DiLeu_BaEn_1 | 408 | 413 | PF01217 | 0.670 |
TRG_DiLeu_LyEn_5 | 408 | 413 | PF01217 | 0.670 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 387 | 390 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 186 | 188 | PF00400 | 0.478 |
TRG_NES_CRM1_1 | 128 | 141 | PF08389 | 0.439 |
TRG_NES_CRM1_1 | 213 | 225 | PF08389 | 0.293 |
TRG_NES_CRM1_1 | 90 | 103 | PF08389 | 0.474 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2J8 | Leptomonas seymouri | 76% | 100% |
A0A0S4IT07 | Bodo saltans | 57% | 100% |
A0A1X0NLS5 | Trypanosomatidae | 59% | 100% |
A0A3R7JZE2 | Trypanosoma rangeli | 59% | 100% |
A0A3S7WPA7 | Leishmania donovani | 92% | 100% |
A4HSP2 | Leishmania infantum | 92% | 100% |
C9ZNE6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AKM7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O35125 | Mus musculus | 26% | 100% |
P21793 | Bos taurus | 28% | 100% |
P22194 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 100% |
P36047 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 32% | 100% |
P45969 | Caenorhabditis elegans | 33% | 100% |
Q15435 | Homo sapiens | 38% | 100% |
Q32PL1 | Danio rerio | 37% | 100% |
Q3T0W4 | Bos taurus | 35% | 100% |
Q3UM45 | Mus musculus | 37% | 100% |
Q4QJ81 | Leishmania major | 91% | 100% |
Q54Q39 | Dictyostelium discoideum | 35% | 100% |
Q5HZV9 | Rattus norvegicus | 37% | 100% |
Q5RFS7 | Pongo abelii | 37% | 100% |
Q6DIQ3 | Xenopus tropicalis | 38% | 100% |
Q7SXW3 | Danio rerio | 28% | 70% |
Q84WJ9 | Arabidopsis thaliana | 36% | 100% |
Q8AVI4 | Xenopus laevis | 27% | 72% |
Q8S7M7 | Oryza sativa subsp. japonica | 27% | 77% |
Q8VYG9 | Arabidopsis thaliana | 27% | 84% |
Q9TTE2 | Ovis aries | 28% | 100% |
V5ARU0 | Trypanosoma cruzi | 59% | 100% |